Association between myelodysplastic syndromes and inflammatory bowel diseases. Report of seven new cases and review of the literature

Leukemia

Volumn 11, Issue 12, 1997, Pages 2188-2191

  Hebbar, M ^a   Kozlowski, D ^a   Wattel, E ^a   Mastrini, S ^a   Dievart M ^a   Duclos, B ^b   Bonaz, B ^c   D'Almagne, H ^d   Belaiche, J ^e   Colombel, J F ^a   Fenaux, P ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d HÔPITAL ROTHSCHILD   (France)

^e UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Crohn's disease; Myelodysplastic syndrome; Ulcerative colitis

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HUMAN; MALE; MYELODYSPLASTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 17344372458     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400863     Document Type: Article

References (21)

1. Bennett JM, Catovsky D, Daniel MT, Llandrin G, Gallon DA, Gralnick HR et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189-199.
2. Morel P, Hebbar M, Lai JL, Duhamel A, Preudhomme C, Wattel E, Bauters F, Fenaux P. Cytogenetic analysis has a strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia 1993; 7: 1315-1323.
3. Hamblin TJ. Immunologic abnormalities in myelodysplastic syndromes. Semin Hematol 1996; 33: 150-162.
4. Podolski DK. Inflammatory bowel disease. New Engl J Med 1991; 325: 1008-1016.
5. Eng C, Farraye FA, Shulman LN, Peppercorn MA, Krauss CM, Connors JM, Stone RM. The association between the myelodysplastic syndromes and Crohn's disease. Ann Intern Med 1992; 117: 661-662.
6. Sahay R, Prangnell DR. Inflammatory bowel disease and refractory anaemia (myelodysplasia). Gut 1993; 34: 1630-1631.
7. Boberg KM, Brinch L, Vatn M. Crohn's disease and the myelodysplastic syndrome. Ann Intern Med 1995; 122: 395-403.
8. Tani T, Sakai Y, Ohtake M, Hatakeyama K. Simultaneous development of Crohn's disease and myelodysplastic syndrome progressing to acute myelocytic leukemia in a patient with normal karyotype. J Gastroenterol 1996; 31: 599-602.
9. Lee-Elliot C, Alexander J, Could A, Talbot R, Snook JA. Langerhan's cell histiocytosis complicating small bowel Crohn's disease. Gut 1996; 38: 296-298.
10. Halme L, Knorring J, Elonen E. Development of acute myelocytic leukemia in patients with Crohn's disease. Dig Dis Sci 1990; 35: 1553-1556.
11. Enright H, Jacob HS, Vercellotti G, Howe R, Belzer M, Miller W. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. Br J Haematol 1995; 91: 403-408.
12. Castro M, Conn DT, Daniel WP, Garton JP. Rheumatic manifestations in myelodysplastic syndromes. J Rheumatol 1991; 18: 721-727.
13. Fenaux P, Estienne MH, Morel P, Lai JL, Gardin C, Jouet JP, Bauters F. De novo myelodysplastic syndromes in adults aged 50 years or less. A report on 37 cases. Leukemia Res 1990; 14: 1053-1059.
14. Polito JM, Childs B, Mellits D, Tokayer AZ, Harris ML, Bayless TM. Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterol 1996; 111: 580-586.
15. Fenaux P. Myelodysplastic syndromes. Hematol Cell Ther 1996; 38: 363-380.
16. Gower-Rousseau C, Salomez JL, Dupas JL, Marti R, Nuttens MC, Votte A, Lemahieu M, Lemaire B, Colombel JF, Cortot A. Incidence of inflammatory bowel disease in northern France (1988-1990). Gut 1994; 35: 1433-1438.
17. Hebbar M, Brouillard M, Wattel E, Decoulx M, Hatron PY, Devulder B, Fenaux P. Association of myelodysplastic syndrome and relapsing polychondritis: further evidence. Leukemia 1995; 9: 731-733.
18. George SW, Newman ED. Seronegative inflammatory arthritis in the myelodysplastic syndromes. Semin Arthr Rheum 1992; 21: 345-354.
19. Reimund JM, Wittersheim C, Dumont S, Muller CD, Kenney JS, Baumann R, Poindron P, Duclos B. Increased production of tumor necrosis factor-α, interleukin-1β, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut 1996; 39: 684-689.
20. Nisse C, Lorthois C, Dorp V, Eloy E, Haguenoer JM, Fenaux P. Exposure to occupational and environmental factors in myelodysplastic syndromes. Preliminary results of a case control study. Leukemia 1995; 9: 693-699.
21. Koutroubakis I, Manousos ON, Meuwissen SGM, Pena AS. Environmental risk factors in inflammatory bowel diseases. Hepato-Gastmenterol 1996; 43: 381-393.